Literature DB >> 29608690

Loss of MicroRNA-21 Influences the Gut Microbiota, Causing Reduced Susceptibility in a Murine Model of Colitis.

Daniel G W Johnston1,2, Michelle A Williams2, Christoph A Thaiss3, Raul Cabrera-Rubio4, Mathilde Raverdeau1, Craig McEntee1, Paul D Cotter4, Eran Elinav3, Luke A J O'Neill1, Sinéad C Corr2.   

Abstract

BACKGROUND AND AIMS: microRNAs regulate gene expression and influence the pathogenesis of human diseases. The present study investigated the role of microRNA-21 [miR-21] in the pathogenesis of intestinal inflammation, because miR-21 is highly expressed in inflammatory bowel disease. Inflammatory bowel disease is associated with intestinal barrier dysfunction and an altered gut microbiota. Recent studies have demonstrated that host microRNAs can shape the microbiota. Thus, we determined the influence of miR-21 on the gut microbiota and observed the subsequent impact in a dextran sodium sulphate [DSS]-induced colitis model.
METHODS: The influence of miR-21 on the gut microbiota and inflammation was assessed in wild-type [WT] and miR-21-/- mice, in co-housed mice, following antibiotic depletion of the microbiota, or by colonization of germ-free [GF] mice with fecal homogenate, prior to DSS administration. We carried out 16S rRNA sequencing on WT and miR-21-/- mice to dissect potential differences in the gut microbiota.
RESULTS: miR-21-/- mice have reduced susceptibility to DSS-induced colitis compared with WT mice. Co-housing conferred some protection to WT mice, while GF mice colonized with fecal homogenate from miR-21-/- were protected from DSS colitis compared with those colonized with WT homogenate. Further supporting a role for the microbiota in the observed phenotype, the protection afforded by miR-21 depletion was lost when mice were pre-treated with antibiotics. The 16S rRNA sequencing revealed significant differences in the composition of WT and miR-21-/- intestinal microbiota.
CONCLUSIONS: These findings suggest that miR-21 influences the pathogenesis of intestinal inflammation by causing propagation of a disrupted gut microbiota.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29608690     DOI: 10.1093/ecco-jcc/jjy038

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  19 in total

1.  Dynamics of Small Non-coding RNA Profiles and the Intestinal Microbiome of High and Low Weight Chickens.

Authors:  Hao Zhou; Lingyu Yang; Jinmei Ding; Ke Xu; Jiajia Liu; Wenqi Zhu; Jianshen Zhu; Chuan He; Chengxiao Han; Chao Qin; Huaixi Luo; Kangchun Chen; Yuming Zheng; Christa F Honaker; Yan Zhang; Paul B Siegel; He Meng
Journal:  Front Microbiol       Date:  2022-06-30       Impact factor: 6.064

2.  Oral Administration of miR-30d from Feces of MS Patients Suppresses MS-like Symptoms in Mice by Expanding Akkermansia muciniphila.

Authors:  Shirong Liu; Rafael M Rezende; Thais G Moreira; Stephanie K Tankou; Laura M Cox; Meng Wu; Anya Song; Fyonn H Dhang; Zhiyun Wei; Gianluca Costamagna; Howard L Weiner
Journal:  Cell Host Microbe       Date:  2019-11-26       Impact factor: 21.023

Review 3.  Gut Microbiome and Neuroinflammation in Hypertension.

Authors:  Elaine M Richards; Jing Li; Bruce R Stevens; Carl J Pepine; Mohan K Raizada
Journal:  Circ Res       Date:  2022-02-03       Impact factor: 17.367

Review 4.  MicroRNA and Gut Microbiota: Tiny but Mighty-Novel Insights into Their Cross-talk in Inflammatory Bowel Disease Pathogenesis and Therapeutics.

Authors:  Maite Casado-Bedmar; Emilie Viennois
Journal:  J Crohns Colitis       Date:  2022-07-14       Impact factor: 10.020

5.  Dietary Arginine Regulates Severity of Experimental Colitis and Affects the Colonic Microbiome.

Authors:  Kshipra Singh; Alain P Gobert; Lori A Coburn; Daniel P Barry; Margaret Allaman; Mohammad Asim; Paula B Luis; Claus Schneider; Ginger L Milne; Helen H Boone; Meghan H Shilts; M Kay Washington; Suman R Das; M Blanca Piazuelo; Keith T Wilson
Journal:  Front Cell Infect Microbiol       Date:  2019-03-26       Impact factor: 5.293

6.  Concentrates of two subsets of extracellular vesicles from cow's milk modulate symptoms and inflammation in experimental colitis.

Authors:  Abderrahim Benmoussa; Idrissa Diallo; Mabrouka Salem; Sara Michel; Caroline Gilbert; Jean Sévigny; Patrick Provost
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

Review 7.  Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis.

Authors:  Simona Iacob; Diana Gabriela Iacob
Journal:  Front Microbiol       Date:  2019-08-07       Impact factor: 5.640

Review 8.  MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker.

Authors:  Ha Thi Nguyen; Salah Eddine Oussama Kacimi; Truc Ly Nguyen; Kamrul Hassan Suman; Roselyn Lemus-Martin; Humaira Saleem; Duy Ngoc Do
Journal:  Biology (Basel)       Date:  2021-05-08

9.  Regulation of Colonic Mucosal MicroRNA Expression via Multiple Targets in Visceral Hypersensitivity Rats by Tongxieyaofang.

Authors:  Guanqun Chao; Yingying Wang; Fangxu Ye; Shuo Zhang
Journal:  Yonsei Med J       Date:  2018-10       Impact factor: 2.759

10.  Ginger in patients with active ulcerative colitis: a study protocol for a randomized controlled trial.

Authors:  Forough Shayesteh; Fatemeh Haidari; Ali Akbar Shayesteh; Javad Mohammadi-Asl; Kambiz Ahmadi-Angali
Journal:  Trials       Date:  2020-03-18       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.